Susquehanna International Group
KZR

Susquehanna International Group’s Kezar Life Sciences KZR Stock Holding History

Susquehanna International Group’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.11M Buy
149,800
+31,100
+26% +$202K ﹤0.01% 7602
2025
Q4 		$747K Buy
+118,700
New +$692K ﹤0.01% 7873
2025
Q2 		– Sell
-11,800
Closed -$57.6K – 13250
2025
Q1 		$57.6K Sell
11,800
-400
-3% -$2.43K ﹤0.01% 11811
2024
Q4 		$82K Buy
+12,200
New +$90.9K ﹤0.01% 11459
2024
Q1 		– Sell
-7,880
Closed -$74.9K – 12801
2023
Q4 		$74.9K Hold
7,880
– – ﹤0.01% 11518
2023
Q3 		$93.8K Sell
7,880
-20
-0.3% -$354 ﹤0.01% 10973
2023
Q2 		$194K Hold
7,900
– – ﹤0.01% 10304
2023
Q1 		$247K Sell
7,900
-960
-11% -$55.5K ﹤0.01% 10143
2022
Q4 		$624K Buy
8,860
+5,120
+137% +$380K ﹤0.01% 7301
2022
Q3 		$322K Sell
3,740
-17,580
-82% -$1.71M ﹤0.01% 9615
2022
Q2 		$1.76M Buy
21,320
+3,970
+23% +$350K ﹤0.01% 5180
2022
Q1 		$2.88M Buy
17,350
+13,240
+322% +$1.9M ﹤0.01% 4701
2021
Q4 		$687K Buy
+4,110
New +$464K ﹤0.01% 8315
2020
Q3 		– Sell
-7,690
Closed -$398K – 10867
2020
Q2 		$398K Buy
+7,690
New +$388K ﹤0.01% 7827

Other funds holding KZR

BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RC
Rangeley Capital New Canaan, Connecticut $103M AUM 77.36% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

Susquehanna International Group's KZR Position: Q4 2024 in Review

Susquehanna International Group sold out of Kezar Life Sciences (KZR) in Q4 2024, closing a stake of 1,259 shares — an estimated $9.38K sold.

Susquehanna International Group first reported a position in KZR in Q1 2020 and held it in 16 quarters. The position peaked at $1.1M in Q1 2022. 43 funds tracked by Wall St. Rank hold KZR as of Q4 2024.

  • Susquehanna International Group reported no remaining Kezar Life Sciences position as of Q4 2024 after selling out during the quarter.
  • Susquehanna International Group sold 1,259 Kezar Life Sciences shares in Q4 2024, an estimated $9.38K.
  • Susquehanna International Group first reported a position in Kezar Life Sciences in Q1 2020 and held it in 16 quarters.
  • Susquehanna International Group's Kezar Life Sciences position peaked at $1.1M in Q1 2022.
  • 43 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q4 2024.

Based on Susquehanna International Group's 13F filing for Q4 2024, filed 14 Feb 2025.